Home / Systemic hormones / Doxercalciferol
ATC H05BX03 · Other Anti-Parathyroid Agents · updated 2 Nov 2026
Doxercalciferol shortage
As of 2 Nov 2026, Doxercalciferol has a reported shortage in 1 of the 16 countries we track (United States), covering 3 products from 1 company.
Is there a Doxercalciferol shortage?
Yes. As of 2 Nov 2026, Doxercalciferol is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Sanofi SAN · Euronext Paris
Compared with similar medicines
ATC group H05BX · Other Anti-Parathyroid AgentsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1) discontinuation | Sanofi-Aventis U.S. LLC | 10 Dec 2025 | not given | Not stated |
| US | Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1) discontinuation | Sanofi-Aventis U.S. LLC | 10 Dec 2025 | not given | Not stated |
| US | Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1) discontinuation | Sanofi-Aventis U.S. LLC | 10 Dec 2025 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Doxercalciferol shortage?
Yes. As of 2 Nov 2026, Doxercalciferol is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
When will Doxercalciferol be back in stock?
No return date has been given; United States: no date given. These are company estimates reported to each authority.
Why is Doxercalciferol in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Doxercalciferol shortages?
Sanofi.